Friday, September 12, 2014
Mallinckrodt, an Ireland-based global specialty pharmaceutical company, has announced that Gary Phillips, M.D., current senior vice president and chief strategy officer, has been appointed senior vice president and president of the company’s autoimmune and rare disease business, which includes the commercial organization supporting H.P. Acthar Gel.
Biomedical Research Alliance of New York (BRANY) has added a biotechnology expert to its board of directors. Robert L. Van Nostrand has extensive experience in biotechnology finance, including roles as as executive vice president and chief financial officer at OSI Pharmaceuticals, Aureon Biosciences and AGI Dermatics. He has also served as chairman of the New York Biotechnology Association (NYBA) on which he remains an active board member.